Summary
- I remain broadly bearish on the stock market due to high valuations, record margin debt, and rising recession risks, but see select opportunities.
- Defense stocks like Lockheed Martin and Northrop Grumman appear oversold; I am buying this weakness as a hedge against geopolitical risks.
- I favor Pfizer for its 7% yield and AI-driven drug discovery potential, and KBR for its undervalued space division spinoff.
- I expect AI capex spending fatigue to trigger a correction in chip stocks while maintaining high cash levels for flexibility.
da-kuk/E+ via Getty Images
Back in December 2025, I wrote a market outlook article with some predictions, stock picks, and risk factors that I thought investors should consider for 2026. Some of my concerns included increased AI-related job losses, historically high stock market
Analyst’s Disclosure: I/we have a beneficial long position in the shares of KBR, INFQ, LMT, NOC, PFE, AMZN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
